Compounds > glucagon
Page last updated: 2024-09-04

glucagon and Peritoneal Neoplasms

glucagon has been researched along with Peritoneal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carey, RW; Ezdinli, EZ; Holland, JF; Pretlow, TG1
Gómez Gómez, LA; Losada López, I; Masmiquel Comas, L; Nicolau Ramis, JA; Rodríguez Rodríguez, I1
Alzate, GD; Barone, RM; Lacey, C; Low, RN; Sebrechts, CP; Sigeti, JS1
Arnold, R; Barth, P; Byrne, MM; Göke, B; McGregor, GP; Rothmund, M1
Campos, C; Ducla-Soares, J; Ferreira, M; Ginestal-Cruz, A; Gomes, GP; Gonçalves, MD; Silva, HL1

Other Studies

5 other study(ies) available for glucagon and Peritoneal Neoplasms

ArticleYear
Studies on the mechanism of hypoglycemia in a patient with massive intraperitoneal leiomyosarcoma.
    The American journal of medicine, 1966, Volume: 40, Issue:3

    Topics: Blood Glucose; Carbon Dioxide; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrogen-Ion Concentration; Hypoglycemia; Lactates; Leiomyosarcoma; Middle Aged; Peritoneal Neoplasms; Pyruvates; Stomach Neoplasms

1966
[Glucagon perfusion in paraneoplastic hypoglycemia].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3

    Topics: Antineoplastic Agents; Coma; Fatal Outcome; Female; Glucagon; Humans; Hypoglycemia; Infusions, Intravenous; Insulin-Like Growth Factor II; Mesothelioma; Middle Aged; Models, Biological; Palliative Care; Paraneoplastic Syndromes; Perfusion; Peritoneal Neoplasms; Protein Precursors; Recurrence

2009
Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Radiology, 1997, Volume: 204, Issue:2

    Topics: Administration, Oral; Barium Sulfate; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glucagon; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Peritoneal Neoplasms; Prospective Studies; Pseudomyxoma Peritonei; Sensitivity and Specificity; Tomography, X-Ray Computed

1997
Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma.
    Digestion, 2001, Volume: 63, Issue:1

    Topics: Cell Division; Gastrointestinal Transit; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Humans; Intestinal Mucosa; Intestine, Small; Jejunum; Liver Neoplasms; Male; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Peptide Fragments; Peptides; Peritoneal Neoplasms; Protein Precursors

2001
Composite tumor of the main bile duct producing several regulatory peptides.
    The American journal of gastroenterology, 1992, Volume: 87, Issue:5

    Topics: Adult; Bile Duct Neoplasms; Common Bile Duct; Female; Glucagon; Humans; Mucins; Neoplasms, Germ Cell and Embryonal; Omentum; Pancreatic Polypeptide; Peritoneal Neoplasms; Somatostatin

1992